Trials / Completed
CompletedNCT02914548
Study of OPA-15406 Ointment in Patients With Atopic Dermatitis
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Parallel-group Comparison Trial to Assess the Efficacy and Safety of 0.3% and 1% OPA-15406 Ointments in Patients With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 15 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of OPA-15406 ointment in patients with atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPA-15406 | Subjects were treated with assigned 0.3% or 1% OPA-15406 ointment twice daily. |
| DRUG | Placebo | Subjects were treated with assigned 0% OPA-15406 ointment twice daily. |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-09-26
- Last updated
- 2020-07-23
- Results posted
- 2020-06-29
Locations
3 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02914548. Inclusion in this directory is not an endorsement.